Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia

Clinical trial NCT07684469 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07684469
Sponsor: Novartis Pharmaceuticals
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Coronary Syndrome

Start date: 2026-06-30
Primary completion: 2027-02-28
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.